Dyskinesia
News
Parkinson's News Today – The Web's Daily Resource for Parkinson's News
Sept. 8, 2026
Bradykinesia in Parkinson’s disease
News
Parkinson's News Today – The Web's Daily Resource for Parkinson's News
Sept. 8, 2026
Detection of α-synuclein seeding activity in tear fluid as a candidate biomarker for Parkinson's disease
News
SAGE Publications: Journal of Parkinson’s Disease: Table of Contents
Sept. 7, 2026
Co- and multipathologies need serious consideration for understanding Parkinson's disease pathogenesis and designing novel experimental therapeutic strategies
News
SAGE Publications: Journal of Parkinson’s Disease: Table of Contents
Sept. 7, 2026
Early Detection of Selected Neuropathologies in Motor Vehicle Drivers
Trial
N/A
Recruiting
Sept. 7, 2026
A Trial Investigating Lu AF28996 in Adults With Parkinson's Disease Who Have Motor Fluctuations
Trial
Phase 2
Recruiting
Sept. 7, 2026
Alpha-Synuclein PET/CT in Various α-Syn-Related Disease
Trial
N/A
Recruiting
Sept. 7, 2026
Parkinson Progression Marker Initiative Online (PPMI Online)
Trial
N/A
Recruiting
Sept. 7, 2026
Parkinson's Foundation PD GENEration Genetic Registry
Trial
N/A
Recruiting
Sept. 7, 2026
Monoamine Oxidase B PET/CT in Various MAO-B-Related Disease
Trial
N/A
Recruiting
Sept. 7, 2026
Investigating Basal Ganglia-Cortical Physiology During Sleep and Its Modulation by Adaptive Deep Brain Stimulation in Parkinson Disease
Trial
N/A
Active, not recruiting
Sept. 7, 2026
Getting to Know You Survey
News
Parkinson's News Today – The Web's Daily Resource for Parkinson's News
Sept. 7, 2026
Unlocking Business Potential in the Growing Senior Care Market
News
Parking Suns
Sept. 7, 2026
Palliative Care Week 2026- ‘It’s Not What You Think.’
News
Parkinson's Ireland
Sept. 5, 2026
Stem Cells and Parkinson’s
News
Brian Grant Foundation
Sept. 4, 2026
Parkinson’s-linked gene mutations may drive iron buildup in brain cells
News
Parkinson's News Today – The Web's Daily Resource for Parkinson's News
Sept. 4, 2026
A Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early Parkinson's Disease
Trial
Phase 2
Active, not recruiting
Sept. 3, 2026
Real-world Patient Experiences With Inbrija®
Trial
N/A
Not yet recruiting
Sept. 3, 2026
Impact of Subthalamic Nucleus Deep Brain Stimulation on COGnitive and PSYchiatric Symptoms in Parkinson's Disease
Trial
N/A
Recruiting
Sept. 3, 2026
Evaluation of the Effects of Levodopa-Benserazide Drug Combination on Periodontal Status in Patients With Parkinson's Disease
Trial
N/A
Active, not recruiting
Sept. 3, 2026